NY S07753 | 2023-2024 | General Assembly
Status
Spectrum: Bipartisan Bill
Status: Introduced on November 15 2023 - 25% progression
Action: 2024-01-03 - REFERRED TO HEALTH
Pending: Senate Health Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on November 15 2023 - 25% progression
Action: 2024-01-03 - REFERRED TO HEALTH
Pending: Senate Health Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.
Title
Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2024-01-03 | Senate | REFERRED TO HEALTH |
| 2023-11-15 | Senate | REFERRED TO RULES |
Same As/Similar To
A08130 (Same As) 2024-05-14 - held for consideration in health
